OBJECTIVE: To determine whether the mechanisms by which estrone acyl-esters carried by lipoproteins induce the loss of body fat can affect Zucker fa/fa rats, since they are hyperphagic and could not eliminate excess energy through thermogenesis, two aspects essential for the slimming effect of oleoyl-estrone in normal rats. DESIGN: The rats were infused for 28 d (osmotic minipumps) with oleoyl-estrone in liposomes (Merlin-2) at a dose of 3.5 mmol/day Á kg. SUBJECTS: Lean (L) and obese (O) Zucker rats. MEASUREMENTS: Body weight changes. Oxygen consumption, body composition (water, lipid, protein), nitrogen balance, plasma chemistry. RESULTS: Treatment resulted in loss of body weight: 12.0 % (28 g) L, 9.4 % (34 g) O, mainly due to fat: 37.5 % (10.8 g) L, 11.7 % (15.5 g) O and water, preventing further increases in body weight and fat storage. Untreated rats increased their body weight: 10.5 % (24 g) L, 32.2 % (101 g) O and lipid stores: 20.3 % (5.9 g) L, 39.8 % (49.0 g) O, making the differences more marked. On day 28, glucose levels were maintained in all groups; in L, triacylglycerols increased and total cholesterol decreased; O showed no changes in plasma composition. In all rats, food intake decreased with treatment, and heat production (oxygen consumption) was unchanged (L) or slightly decreased (O). Energy expenditure per unit of fat-free mass remained unchanged. Protein balance was maintained in all groups; slimming was achieved without loss of body protein. CONCLUSION: Treatment of genetically obese rats with oleoyl-estrone in liposomes (Merlin-2) results in sustained loss of body weight ± mainly lipid, sparing protein ± for up to 28 d, essentially preventing further increase in body weight and accumulation of lipid and protein. This is achieved through lower food intake and relatively small changes (if any) in energy expenditure.
Introduction
Fatty acyl esters of estrone, carried by lipoproteins, are part of an inter-tissue signalling system which forms part of the body weight control system. 1 Chronic pharmacological administration of oleoylestrone (Merlin-2) to normal rats results in the progressive loss of their fat stores because of lower food intake combined with maintained energy expenditure. 1 Most of the injected oleoyl-estrone is rapidly inactivated to estrone, 2 which affects body weight quite differently from the ester. 1 In fact, estrone administration tends to increase body weight. 1 Zucker fa/fa rats are a widely used model of obesity, as they lack a fully operational thermogenic system, 3, 4 which limits the animals' ability to survive in the cold, 5 and makes them much more dependent on metabolic residual heat to maintain their thermal homeostasis. 6 In Zucker fa/fa rats, brown adipose tissue thermogenesis is practically nil under standard conditions 7 and can be only partially elicited through pharmacological infusion of catecholamines. 7, 8 The type of obesity shared by fa/fa rats and db/db mice is not responsive to leptin, 9, 10 since it is characterized by having mutant non-functional leptin receptors. 11 The special circumstances of the genetic obesity of Zucker fa/fa rats make them suitable for exploration of the mechanisms by which estrone acyl-esters carried by lipoproteins act, since Zucker fa/fa rats are hyperphagic 12 and cannot eliminate excess energy through thermogenesis, 4 two aspects essential for the slimming effect of oleoyl-estrone in normal rats. 1 In addition, the lack of responsiveness of this model to leptin may enable the relationship between leptin and lipoprotein acyl-estrone systems to be understood, which is why this study examined the effect of chronic oleoyl-estrone administered in liposomes (Merlin-2), on body weight and fat store changes in Zucker obese fa/fa rats, compared with phenotypically lean counterparts (Fa/?).
Materials and methods

Animals and food
Female adult 14-week old Zucker lean (Fa/?) and obese ( fa/fa) rats from Charles River (France), weighing 220±240 g and 280±320 g respectively, were used. The rats were maintained in metabolic cages (Techniplast Gazzada, Guguggiatte, Italy) under standard conditions (21 C, 60±70 % relative humidity, lights on 08.00±20.00 h), and fed ad libitum standard rat chow pellets (B&K, Sant Vicent dels Horts, Spain), with a composition of 120 g/kg water, 587 g/kg digestible carbohydrate, 30 g/kg lipid, 178 g/kg protein and 85 g/kg other components (mainly ®bre and minerals), and an energy equivalence, after correcting for digestibility, of 13.87 MJ/kg.
Chronic infusion experiments
Oleoyl-estrone was synthesized and incorporated into liposomes to produce the Merlin-2 preparation as previously described;
1 a standard dose of 3.5 mmol/ day Á kg of oleoyl-estrone was used. This dose was in the lower range of the amount of Merlin-2 provoking maximal slimming effects on normal rats. 1 Alzet osmotic minipumps (model 2ML2; Alza, Palo Alto, CA, USA), providing a rate of release of 5 ml/h for 14 d, were ®lled with either Merlin-2 or hormonefree liposomes. The minipumps were surgically implanted under the skin on the back of rats anaesthetized with ethyl ether; the minipumps were connected ± using a short PE10 polyethylene tube (Beckton Dickinson, Parsipanny, NJ, USA) ± into the left jugular vein. The rats were weighed daily and their food consumption recorded. Urine and droppings were also recovered daily, and were weighed, sampled and used to determine total nitrogen content with a Carlo Erba model NA-1500 elemental analyser. Half of the animals in each series, lean and obese, were reimplanted on day 14 with new osmotic minipumps, ®lled with either liposomes or Merlin-2 at the same doses, in order to prolong the treatment for 2 additional weeks.
Body composition analysis
At the end of the study, all rats were killed by decapitation. Part of the blood was recovered in heparinized beakers and used to obtain plasma, which was then stored at 720 C until processed. The corpses were dissected and the intestine cleaned of its contents; whole rats (including the blood shed) were put into sealed polyethylene bags and autoclaved at 120 C for 2 h. After cooling, the contents of the bags were minced with a blender to a ®ne paste. Part of this was used for the measurement of water content by differential weighing after desiccation (24 h at 105±107 C). The paste was used for the calculation of total lipids 13 and nitrogen content. Conversion of nitrogen to protein was calculated by using a 5.5 conversion factor. 14 The changes in body composition were correlated with actual body weight changes to determine the gain or loss of water, protein and lipid.
Blood plasma samples were used for the calculation of glucose, urea, cholesterol, and triacylglycerols using standard dry biochemistry methods (Spotchem, strips I and II, Menarini, Firenze, Italy).
Respirometry
During the period of study, the rats' energy expenditure was calculated by means of indirect calorimetry in a closed chamber, as previously described, 15 which allowed the estimation of oxygen consumption, carbon dioxide production and the respiratory quotient. The rats were kept in the chamber for 1 h periods (within the 12.00±14.00 h period). In order to prevent excessive in¯uence of handling, the rats were used for these measurements once every three days. Gas measurements were taken in each case for 45 min at 10 s intervals. The energy equivalence of oxygen consumption was calculated using a conversion factor of 448 kJ/mol O 2 . 16 The results obtained were matched with the energy equivalent of food ingested and absorbed, calculated as described above.
The statistical signi®cance of differences between groups was assessed by using the Student's t test.
Results
Treatment of lean and obese rats with oleoyl-estrone in liposomes (Merlin-2) resulted in the loss of body weight in both groups (Figure 1) . In lean rats, after about 10 d of treatment, no further weight losses were observed. Also in the obese animals a continued decline in body weight was not visible after the implantation of the second Alzet pump with Merlin-2. In contrast, control rats, receiving only liposomes with no oleoyl-estrone, kept increasing their weight slowly but progressively for the entire period studied. The surgical implantation of the minipumps (and their substitution on day 14) resulted in transient losses of weight in all four groups.
The loss of weight was in part due to lowered food intake in all treated animals, as can be seen in Figure  2 . The effects of Merlin-2 on food ingestion were more marked in the obese than in the lean rats, whose energy intake was lowered by 25%, whereas the obese decreased food ingestion by 40%. Surgical implantation of the minipumps markedly in¯uenced food intake in all four groups. In control lean rats, food intake increased slowly during the ®st two weeks of the study, and was stabilized in the last two. Treated lean rats followed a similar pattern, but started from a lower initial stabilized intake level. In control obese rats, food consumption was fairly uniform for the duration of the experiment; in the treated obese rats, however, food intake decreased for most of the ®rst half of the period studied, a trend that was reversed in the second half. Table 1 summarizes the changes in the rats' weight and body composition. After 28 d of treatment, the difference between control and treated rats was 22% (lean) and 43% (obese) of the initial weight. Lipid loss was greater in the obese rats, but lower in percentage than in the lean group; and the loss of protein was practically nil. The data were much more signi®cant when compared, not with the initial situation, but with the ®nal data of the control group. In all, the 28 d treatment resulted in a difference of 17 g (lean) and 65 g (obese) between the control group and treated animals, which is practically half of the lipid initially present in the rats.
Treated rats had, at the end of the treatment about the same protein as they had at the beginning, but the control group accrued a signi®cant amount of protein, especially in the case of obese rats, on account of their extreme increase in weight. The nitrogen balance study agreed with the data on body composition (Table 2 ). Lean control rats showed fairly uniform nitrogen intake during the period studied, with stable urine and fecal losses, resulting in a positive nitrogen balance. The rats treated with Merlin-2 showed unchanged urinary excretion and stool nitrogen despite lowered nitrogen intake, which resulted in the end in practically zero nitrogen balance. In the case of obese rats, the differences between both groups were larger, since the net nitrogen balance of the control group was clearly positive and again practically zero in the treated group. Figure 3 depicts the energy output of control and treated rats, corrected by an allometric factor 17 that renders the data of lean and obese rats comparable. As expected, lean rats had a higher heat output than the obese ones. There were no changes in heat production over time in any of the four groups studied when the data were corrected allometrically for body size. Table 3 summarizes, in uniform units, the energy balance of lean and obese rats subjected to treatment Statistical signi®cance of the differences (ANOVA): there was a signi®cant difference between the control and treated groups for both lean and obese rats. Statistical signi®cance of the differences (ANOVA): there was a signi®cant difference between the control and treated groups for both lean and obese rats.
Effect of oleoyl-estrone on Zucker obese rats F Balada et al with Merlin-2. In control lean rats, the energy gain was slightly positive and in the same range as the total energy stored, in spite of energy intake and energy output being data not directly comparable. Treatment with Merlin-2 increased the energy gain gap, mainly covered by stored lipid.
In the obese rats, the differences in energy gain were more marked than in the lean ones, the controls using about a quarter of the available energy for storage. The decrease in energy intake of obese rats treated with Merlin-2 was 41% of the controls' values, but the fall in energy output was only 17%, which meant a steady loss of stored energy, mainly, again, in the form of lipid. Treatment with Merlin-2 did not affect energy expenditure when expressed per unit of fat-free mass. Table 4 shows the plasma composition of lean and obese rats and the effect of Merlin-2 treatment on it. Glycaemia was well maintained in treated rats; again no changes were observed in urea levels, higher in the obese ones. Triacylglycerols and cholesterol levels were higher in the obese group. In lean rats, Merlin-2 administration led to an increase in triacylglycerols and a decrease in cholesterol, a situation that contrasted with the nil changes experienced by the obese rats. The data are the mean AE SEM of 5±7 different animals. Single data correspond to calculated values. Data in italics are assumed to correspond to the same group of animals, but were not obtained directly from them but from a parallel group. All rats on day 0 were assumed to share the same body composition. The rats treated with Merlin-2 received 3.5 mmol/day Á kg of oleoyl-estrone in a liposome preparation during 2 consecutive 14 d periods; the control group received hormone-free liposomes. Statistical signi®cance of the differences between groups (P`0.05): * difference between initial and day 28 data; # difference between treated and control groups;
{ difference between lean and obese. 1 Percentage of the initial mass of water/lipid/protein The values presented are expressed in g of N per 28 d of treatment, and are the mean AE SEM of 5±6 different animals per group. Single data are values calculated from the other data available. The rats treated with Merlin-2 received 3.5 mmol/day Á kg of oleoyl-estrone in a liposome preparation during two consecutive 14 d periods; controls received hormone-free liposomes. Statistical signi®cance of the differences between groups (P`0.05): # difference between treated and control groups; { difference between lean and obese. 1 Difference between ingested and stool nitrogen. 2 Difference between available and urinary nitrogen. 3 Data calculated from values in Table 1 Effect of oleoyl-estrone on Zucker obese rats F Balada et al
Discussion
Oleoyl-estrone treatment lowers the body mass of rats, mainly by lowering food intake, maintaining energy expenditure and thus inducing the active utilization of internal stores. 1 The loss of weight is fundamentally a loss of fat, accompanied by water and protein, the latter to a lesser degree. 1 The apparent limit to the exhaustion of fat stores is their size, along with the intensity of the treatment. 1 The results obtained agree with this, since lean rats lost only about 10% of their weight, but a sizeable proportion of their lipids. It must be borne in mind however, that tissue energystoring triacylglycerols are only a fraction of lean rat's lipid content, so a loss like that observed here accounts for most of these rat's lipid energy stores. In the obese ones, however, the situation is different, as they lost only a relatively small part of their lipid stores (in any case larger to begin with than those of the lean ones). Nevertheless, the most impressive effect of Merlin-2 was observed when rat weight and lipid content were compared, not with the initial situation but with the levels attained by the untreated control group. In about one month of treatment at a dose in the lower range eliciting a maximal response on Wistar rats, 1 there were differences of about half the initial weight between treated and control obese The values presented are the mean AE SEM of 5±6 different animals per group. The rats treated with Merlin-2 received 3.5 mmol/day Á kg of oleoyl-estrone in a liposome preparation during 2 consecutive 14 d periods; controls received hormone-free liposomes. Statistical signi®cance of the differences between groups (P`0.05): # difference between treated and control groups; { difference between lean and obese. 1 Values calculated as a mean for the 28 d period from the total amount of food ingested, its energy equivalent and an assumed ef®ciency of 95% for assimilative processes.
2 Values calculated as a mean for all the 45 min periods in which oxygen consumption and carbon dioxide production were measured in the closed chamber system. 3 Energy expenditure in W per kg of fatfree mass. 4 Arithmetic difference between the means for energy intake and energy output. 5 Value calculated from the net gain/loss of protein and lipid presented in Table 1 , converted into its energy equivalence and assumed to be distributed over the 28 d period studied. These values are the sum of the two following data. 6 Total energy stored in the form of protein; a conversion factor of 23 kJ/g was used for protein deposition and 17 kJ/g for metabolic utilization. 7 Total energy stored in the form of lipid; a conversion factor of 39 kJ/g was used. Figure 3 Energy expenditure of rats receiving a continuous infusion of liposomes loaded with oleoyl-estrone (Merlin-2). The data on energy output are corrected by an allometric factor in order to render directly comparable the lean and obese rats different body mass. The columns represent the mean AE SEM of all means taken during the 28 d period. The dotted line and diamonds mark the maximal and minimal values for each column obtained from individual rats, i.e. the absolute range of variation of this parameter.
Statistical signi®cance of the differences (ANOVA): no signi®-cant difference was found between the control and treated groups for either lean or obese rats. There was a signi®cant difference between lean and obese rats as a whole. { difference between lean and obese.
Effect of oleoyl-estrone on Zucker obese rats F Balada et al rats, the change being most marked in lipid and least in protein.
In spite of the large mass of water lost by the treated rats, the percentage of this major component was maintained with respect to total body eight. Merlin-2 treatment did not change this percentage. The progressive loss of water can be explained because of the large mass of water implied in the daily water turnover. 18 The amount of water lost could be justi®ed as a mere daily 3% (in the lean and 1.6% in in the obese) of the mass of water lost by the rat for a period of 28 d. 18 It must be borne in mind that the data for energy balance obtained from 45 min periods of oxygen consumption measurement, with the rat awake and active, are not necessarily directly comparable to the energy measurement from food intake, which refers to much wider periods. In spite of their different origins, the data can be used to compare the behaviour of different groups. 19 Thus, the data in Table 3 should be taken only as a relative (comparative) approach. However, these data and those gathered from body composition ®t fairly well into the overall calculation of energy balance.
In the obese rats, the fall in energy output was more marked than in the lean ones, as was the effect on food intake. The combined result of these two processes was the prevention of further increase in fat deposition and a constant drain on the reserves. The fall in heat production can be in part due to the lack of functional brown adipose tissue thermogenesis in fa/fa rats. 7 They obtain a signi®cant amount of the heat needed for thermoregulation from residual metabolic energy obtained in the conversion of dietary carbohydrate into fat. 6 The limitation of food intake, thus, affects more intensely their overall heat production than in the case of lean rats, in which brown adipose tissue thermogenesis is maintained. However, when the energy expenditure ®gures were expressed per unit of fat-free mass weight, there were no differences between lean and obese rats or controls and treated with Merlin-2. This is in agreement with the known slimming effects of Merlin-2: maintenance of energy expenditure and decrease in food intake. 1 The loss of fat in obese rats under treatment with Merlin-2 was maintained for the 28 d period studied. The experimental approach used prevented the continuation of the experiment, because of complications ensuing from surgery for minipump re-implantation: the surgical stress was small but nevertheless noticeable, namely from the indents in the food intake curve. The data gathered, however, suggest that obese rats could maintain the weight loss (and especially not gaining it) for an indeterminate period of time, in contrast with lean rats, who cannot lose more weight after their lipid stores become exhausted. 1 All these changes occurred under conditions in which plasma chemistry does not change much. Blood glucose was well maintained in all groups. Plasma triacylglycerol levels in obese rats remained unchanged by treatment, as did total cholesterol, whereas in the lean ones cholesterol was actually lowered despite an increase in circulating triacylglycerols, which not even under these conditions reached the basal concentration of the obese rats.
The effects of oleoyl-estrone treatment on nitrogen metabolism were comparable to those already observed for shorter periods in Wistar rats. 1 The decrease in food consumption elicits a further conservation of nitrogen, with only fractionally decreased excretion. Zucker obese rats show no signi®cant changes in the management of dietary protein compared with their lean littermates, except for increased protein deposition accompanying their marked expansion of lipid stores. 20 The data for obese controls agrees with this interpretation. Treatment with oleoyl-estrone did not signi®cantly affect body protein, a point that contrasts with the known utilization of body protein as energy source under conditions of limited food intake, 21 which is re¯ected in a negative nitrogen balance. 22 The treatment with Merlin, however, preserved body protein to a large extent, but caused the total oxidation of dietary protein. This situation contrasts with that of obese controls and obesity in general, in which the abundance of dietary energy spares protein, facilitating the synthesis and accumulation of protein. 20 The metabolic environment of obese treated rats, with its relative limitation of energy, completely changed the situation, and limited further the availability of amino acids for protein deposition. The maintenance, but prevention of increase in body protein may be an additional factor in the stunting of further growth in treated obese rats.
The steady loss of weight in Merlin-2-treated obese rats contrasted with the unresponsiveness to leptin. 10 This suggests that the fa mutation does not affect the ability of Merlin-2 to induce weight loss. The results obtained also imply that the mechanism of action of oleoyl-estrone does not involve the leptin pathway, in spite of the coincidence of leptin and Merlin-2 in maintaining heat output while lowering food intake. 1, 23 This implies the intervention of at least two complementary mechanisms: an inhibition of appetite, probably mediated by modulation of hypothalamic neuropeptide Y levels, and the inhibition of low-intake decrease in thermogenic activity, an action that is maintained in the Zucker obese rats in spite of the ineffectiveness of the uncoupling protein-1 pathway in brown adipose tissue. 3 Perhaps these thermogenic effects are mediated through stimulation of widely distributed 24 uncoupling protein-2.
Conclusions
The main conclusion which can be drawn from this study is that the treatment of genetically obese rats with oleoyl-estrone in liposomes (Merlin-2) results in 
